Displaying results 1 - 8 of 8
Public Health and Advocacy
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View
Public Health and Advocacy
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Public Health and Advocacy
EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

Podcasts
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

Podcasts
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline - GE version

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF
View
General Hepatology
EHC on-demand Webinar: Pathways towards liver health: Focus on care post-viral infection and post-gene therapy

EHC on-demand Webinar: Pathways towards liver health: Focus on care post-viral infection and post-gene therapy

On-demand Webinars
View
Immune-Mediated and Cholestatic Diseases
EASL Studio S4 E7: Genetics in adult liver disease – missed opportunities?

EASL Studio S4 E7: Genetics in adult liver disease – missed opportunities?

EASL Studio
View
Displaying results 1 - 8 of 8